Guardant Health, Inc.

GH Healthcare Diagnostics & Research

Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.

Revenue
+36.1%
EPS
−25.7%
Free cash flow
+18.7%
Total debt
+34.8%

Quarter to September 2026, against a year earlier

154.16 14.42 −8.55%
Market cap
$20.6B
P/E
0.0×
Fwd P/E
−55.6×
Dividend yield
—
F-score
5/9
Altman Z
2.02
Beneish M
−2.78
Dividend safety
n/a

Guardant Health, Inc. (GH) Free cash flow

Alert me on Free cash flow

Guardant Health, Inc.'s free cash flow for fiscal 2025 was −$233.1M, compared with −$274.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$232.1M. Over the past ten years it has ranged from −$386.9M (fiscal 2022) to −$38.5M (fiscal 2016); the current reading is higher than 50% of that period. Free cash flow has risen for 3 consecutive fiscal years. Guardant Health, Inc. ranks 48th of 49 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 −$233.1M —
FY2024 −$274.9M —
FY2023 −$345.5M —
FY2022 −$386.9M —
FY2021 −$284.1M —
FY2020 −$158.0M —
FY2019 −$68.4M —
FY2018 −$92.4M —
FY2017 −$78.9M —
FY2016 −$38.5M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 −$37.2M —
Jun 2026 −$69.5M —
Mar 2026 −$71.2M —
Dec 2025 −$54.2M —
34 more quarters

Against its own ten years

Low −$386.9M High −$38.5M
Ten-year median −$195.5M
Current reading's percentile 50

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on GH